Bank Paul Cd, Swen Jesse J, Guchelaar Henk-Jan
Department of Clinical Pharmacy & Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.
Pharmacogenomics. 2017 Feb;18(3):215-225. doi: 10.2217/pgs-2016-0138. Epub 2017 Jan 23.
To benchmark Dutch pharmacists knowledge, experience and attitudes toward pharmacogenetics (PGx) with a specific focus on the effects of awareness of the Dutch Pharmacogenetics Working Group guidelines.
A web-based survey containing 41 questions was sent to all certified Dutch pharmacists.
A total of 667 pharmacists completed the survey (18.8%). Virtually all responders believed in the concept of PGx (99.7%). However, only 14.7% recently ordered a PGx test (≤6 months), 14.1% felt adequately informed and 88.8% would like to receive additional training on PGx. Being aware of the Dutch Pharmacogenetics Working Group guidelines did not have any significant effect on knowledge or adoption of PGx.
Dutch pharmacists are very positive toward PGx. However, test adoption is low and additional training is warranted.
以荷兰药物基因组学工作组指南的知晓情况的影响为重点，对荷兰药剂师关于药物基因组学（PGx）的知识、经验和态度进行基准测试。
向所有获得认证的荷兰药剂师发送了一份包含41个问题的网络调查问卷。
共有667名药剂师完成了调查（回复率为18.8%）。几乎所有受访者都相信药物基因组学的概念（99.7%）。然而，最近只有14.7%的人进行了药物基因组学检测（≤6个月），14.1%的人觉得信息充分，88.8%的人希望接受关于药物基因组学的额外培训。知晓荷兰药物基因组学工作组指南对药物基因组学的知识或应用没有任何显著影响。
荷兰药剂师对药物基因组学非常积极。然而，检测的采用率较低，有必要进行额外培训。
